USAMRDCUnited States Army Medical Research & Development Command
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
ContraFect announced that the Congressionally Directed Medical Research Programs, or CDMRP, has awarded the company $7.2M in funding from the Military Infectious Diseases Research Program, or MIDRP, United States Army Medical Research and Development Command, or USAMRDC, over the course of three years to advance its lysin candidate, CF-296, through IND-enabling studies after which it may enter the clinic.